Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Fish and Richardson
Colorcon
Dow
Chinese Patent Office
Julphar
Chubb
QuintilesIMS
Baxter

Generated: December 11, 2018

DrugPatentWatch Database Preview

ZOLOFT Drug Profile

« Back to Dashboard

Which patents cover Zoloft, and what generic alternatives are available?

Zoloft is a drug marketed by Pfizer and is included in two NDAs. There are two patents protecting this drug and one Paragraph IV challenge.

This drug has fifty-two patent family members in forty-five countries.

The generic ingredient in ZOLOFT is sertraline hydrochloride. There are twenty-two drug master file entries for this compound. Sixty-one suppliers are listed for this compound. Additional details are available on the sertraline hydrochloride profile page.

Drug patent expirations by year for ZOLOFT
Pharmacology for ZOLOFT
Medical Subject Heading (MeSH) Categories for ZOLOFT
Synonyms for ZOLOFT
(+)-cis-(1S,4S)-1-methylamino-4-(3,4-dichlorophenyl)tetralin hydrochloride
(+)-Sertraline
(+)-sertraline hydrochloride
(+/-)-Sertraline Hydrochloride
(1 s-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphathalenamine hydrochloride
(1R,4R)-SERTRALINE HCL
(1R,4S)-SERTRALINE HCL
(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine
(1s-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphathalenamine hydrochloride
(1S-cis)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine
(1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine hydrochloride
(1S-cis)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine; (+)-Sertraline; Sertraline
(1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-naphthalenamine
(1S-cis)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride
(1S,4-Dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthyl(methyl)amine hydrochloride
(1S,4S)-[4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPHTHALENYL]METHYLAMINE HYDROCHLORIDE
(1S,4S)-1-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-4-(methylamino)naphthalene Hydrochloride
(1S,4S)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine hydrochloride
(1S,4S)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthylamine hydrochloride
(1S,4S)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-napthalenamine hydrochloride
(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine
(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride
(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine;hydrochloride
(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-aminium chloride
(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-tetralin-1-amine
(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-tetralin-1-amine hydrochloride
(1S,4S)-sertraline
[(1S,4S)-4-(3,4-DICHLORO-PHENYL)-1,2,3,4-TETRAHYDRO-NAPHTHALEN-1-YL]-METHYL-AMINE HYDROCHLORIDE
[(1S,4S)-4-(3,4-dichlorophenyl)(1,2,3,4-tetrahydronaphthyl)]methylamine, chlor ide
[(1S,4S)-4-(3,4-dichlorophenyl)tetralin-1-yl]-methyl-amine;hydrochloride
[4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenyl]methylamine hydrochloride
1-Naphthalenamine, 1,2,3,4-tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-, (1S-cis)-
1-Naphthalenamine, 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-, (1S,4S)-
1-NAPHTHALENAMINE, 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-N-METHYL-, (1S,4S)-, HYDROCHLORIDE
1-NAPHTHALENAMINE, 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-N-METHYL-, HYDROCHLORIDE (1:1), (1S,4S)-
1-Naphthalenamine, 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-, hydrochloride, (1S-cis)-
1-Naphthalenamine, 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-, hydrochloride,(1S-cis)-
1-Naphthalenamine,1,2,3,4-tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-, (1S-cis)-
1-naphthalenamine,1,2,3,4-tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-,(1S-cis)-
4- -1,2,3,4-tetrahydro-N-methyl-1-naphthalenaminehydrochloride
4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-
559S970
617S962
79559-97-0
79559-97-0 (Hydrochloride)
79617-95-1
79617-96-2
79617-96-2 (Parent)
79617-99-5
79951-46-5
A839725
AB00514002
AB00514002_17
AB00514002_18
AB07662
AB1004870
AC-15639
AC-740
AC1L1Y71
AC1L2A41
AC1Q3O5N
AC1Q3XJU
Adjuvin
AJ-32109
AK-72966
AK-87082
AKOS005267232
AKOS015846322
AN-15588
AN-36575
ANW-58187
AOB2376
API0004164
Apo-Sertraline
Aremis
ARONIS24360
Atruline
AX8034967
BC209359
BC216562
BDBM50028094
BDBM79021
BIDD:GT0768
BIDD:PXR0193
BLFQGGGGFNSJKA-XHXSRVRCSA-N
BPBio1_001285
BR-72966
BRD-K82036761-003-02-1
BRN 5753709
BSPBio_001167
BSPBio_002698
C-19042
C-4401
C07246
C17H17Cl2N
C17H17Cl2N.HCl
C17H18Cl3N
CAS-79559-97-0
CC-34407
CCG-221014
CCG-39575
CHEBI:9123
CHEBI:9124
CHEMBL1709
CHEMBL809
cid_63009
cis-(+)-sertraline
Cp 51,974-1
Cp 51974
Cp-51,974-1
cp-51974
CP-51974-1
CP-5197401
CP-519741
CPD000466298
CS-2052
CS0024
CTK8B7684
CTK8E2603
D00825
D02360
D0K0TC
DB01104
DR001262
DSSTox_CID_20243
DSSTox_GSID_40243
DSSTox_RID_79456
DTXSID1040243
DTXSID6023577
EN300-150167
EU-0100870
FT-0081122
FT-0630872
FT-0641726
Gladem
GTPL4798
HMS1922P09
HMS2098K09
HMS2231I09
HSDB 7037
HY-B0176A
I14-16426
J10439
KB-205456
KBio3_001918
KBioGR_001724
KS-00000H1Y
KS-1111
LP00870
LS-94166
LS-94179
Lustral
Lustral (TN)
LUSTRAL HCL
MCULE-1681469163
MCULE-4360779618
MFCD00895772
MLS000758929
MLS001195647
MLS001401398
MLS002222308
MolPort-002-885-860
MolPort-003-666-622
NC00198
NC00726
NCGC00092386-01
NCGC00092386-03
NCGC00092386-04
NCGC00092386-05
NCGC00092386-06
NCGC00092386-07
NCGC00092386-08
NCGC00092386-09
NCGC00092386-10
NCGC00092386-13
NCGC00261555-01
NE57257
NSC-746308
NSC-758948
NSC746308
NSC758948
OR342428
Pharmakon1600-01505262
Prestwick3_001014
PubChem5865
QUC7NX6WMB
rac-cis-Sertraline Hydrochloride
rac-Sertraline Hydrochloride ((1RS,4RS)-4-(3,4-Dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine Hydrochloride)
REGID_for_CID_68617
S0507
S4053
SAM001246666
SAM001247100
SAM002700175
SBB080777
SBI-0206734.P001
SC-16114
SC-16255
SCHEMBL23230
SCHEMBL28701
Serad
Serlift
SERTALINE HYDROCHLORIDE
Sertralina
Sertralina [Spanish]
sertraline
Sertraline (hydrochloride)
Sertraline (INN)
sertraline (Zoloft)
Sertraline [INN:BAN]
Sertraline [Zoloft]
Sertraline for peak identification, European Pharmacopoeia (EP) Reference Standard
Sertraline for system suitability, European Pharmacopoeia (EP) Reference Standard
Sertraline HCl
SERTRALINE HCL FORM I
SERTRALINE HCL FORM II
SERTRALINE HYDRECHLORIDE
Sertraline hydrochloride
Sertraline Hydrochloride (1S-cis)-Isomer
Sertraline hydrochloride (JAN/USAN)
Sertraline hydrochloride [USAN:USP]
Sertraline hydrochloride [USAN]
Sertraline Hydrochloride 1.0 mg/ml in Methanol (as free base)
Sertraline hydrochloride racemic mixture, United States Pharmacopeia (USP) Reference Standard
Sertraline hydrochloride, >=98% (HPLC)
Sertraline hydrochloride, European Pharmacopoeia (EP) Reference Standard
Sertraline hydrochloride, United States Pharmacopeia (USP) Reference Standard
Sertraline Impurity G HCl
Sertraline.HCl
Sertralinum
Sertralinum [Latin]
SMR000466298
SMR000596516
SPBio_000385
SPECTRUM1505262
Spectrum2_000493
Spectrum3_001079
Spectrum4_001232
SRE
ST24031612
syn-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine
Tatig
TBA-2010_Sertraline_1
TL8005382
Tox21_111199
Tox21_111199_1
Tox21_500870
TR-025284
TR-031501
Tresleen
UNII-QUC7NX6WMB
UNII-UTI8907Y6X
UTI8907Y6X
VGKDLMBJGBXTGI-SJCJKPOMSA-N
ZINC1853550
Zoloft (TN)
ZOLOFT HCL
Zoloft, Lustral, Daxid, Altruline, Besitran, Deprax, Elrval, Emergen, Gladem, Implicane, Sedoran, Sealdin, SerivoLowfin, Stimuloton, Tresleen, Sertralin Bluefish

US Patents and Regulatory Information for ZOLOFT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer ZOLOFT sertraline hydrochloride CONCENTRATE;ORAL 020990-001 Dec 7, 1999 AA RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Pfizer ZOLOFT sertraline hydrochloride TABLET;ORAL 019839-004 Dec 30, 1991 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pfizer ZOLOFT sertraline hydrochloride TABLET;ORAL 019839-001 Dec 30, 1991 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for ZOLOFT

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer ZOLOFT sertraline hydrochloride TABLET;ORAL 019839-001 Dec 30, 1991 ➤ Try a Free Trial ➤ Try a Free Trial
Pfizer ZOLOFT sertraline hydrochloride TABLET;ORAL 019839-001 Dec 30, 1991 ➤ Try a Free Trial ➤ Try a Free Trial
Pfizer ZOLOFT sertraline hydrochloride TABLET;ORAL 019839-002 Dec 30, 1991 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for ZOLOFT
Drugname Dosage Strength RLD Date
➤ Subscribe Tablets 150 mg and 200 mg ➤ Subscribe ➤ Try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Medtronic
Fuji
Baxter
Colorcon
QuintilesIMS
Moodys
Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.